Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study

Diabetes Care

Volumn 35, Issue 5, 2012, Pages 1031-1037

  Bower, Julie K ^a,b   Appel, Lawrence J ^a,b,c   Matsushita, Kunihiro ^a,b   Young, J Hunter ^a,b,c   Alonso, Alvaro ^d   Brancati, Frederick L ^a,b,c   Selvin, Elizabeth ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT; STROKE;

ATHEROSCLEROSIS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS; STROKE;

EID: 84862081223     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2248     Document Type: Article

References (38)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl. 1):S62-S69
2. World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva, World Health Org., 2011 (Report no.WHO/NMH/CHP/CPM/11.1)
3. Heianza Y, Hara S, Arase Y, et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011;378:147-155
4. Inoue K, Matsumoto M, Akimoto K. Fasting plasma glucose and HbA1c as risk factors for type 2 diabetes. Diabet Med 2008;25:1157-1163
5. Pradhan AD, Rifai N, Buring JE, Ridker PM. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007;120:720-727 (Pubitemid 47176521)
6. Selvin E, Steffes MW, Zhu H, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010;362:800-811
7. Adams RJ, Appleton SL, Hill CL, et al. Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 2009;17:559-563
8. Sarwar N, Aspelund T, Eiriksdottir G, et al. Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review. PLoS Med 2010;7:e1000278
9. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-431
10. Beevers G, Lip GYH, O'Brien E. ABC of hypertension: the pathophysiology of hypertension. BMJ 2001;322:912-916 (Pubitemid 32324319)
11. Deedwania PC, Fonseca VA. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm. Am J Med 2005;118:939-947 [see comment] (Pubitemid 41297754)
12. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab 2001;86:713-718 (Pubitemid 32207485)
13. de Boer IH, Kestenbaum B, Rue TC, et al.; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med 2008;168:1867-1873
14. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167
15. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303:2043-2050
16. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 2004;44:398-404 (Pubitemid 39281486)
17. Barret-Connor E, Criqui MH, Klauber MR, Holdbrook M. Diabetes and hypertension in a community of older adults. Am J Epidemiol 1981;113:276-284 (Pubitemid 11152579)
18. Bell DSH. Treatment of diabetic hypertension. Diabetes Obes Metab 2009;11:433-444
19. Imperatore G, Cadwell BL, Geiss L, et al. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am J Epidemiol 2004;160:531-539 (Pubitemid 39215629)
20. Preis SR, Pencina MJ, Hwang SJ, et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009;120:212-220
21. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989;129:687-702
22. Selvin E, Steffes MW, Gregg E, Brancati FL, Coresh J. Performance of A1C for the classification and prediction of diabetes. Diabetes Care 2011;34:84-89
23. Atherosclerosis Risk in Communities Coordinating Center. Operations Manual no. 11: Sitting Blood Pressures. Chapel Hill, NC, University of North Carolina School of Public Health, 1990
24. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936-942 (Pubitemid 13214364)
25. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122:51-65 (Pubitemid 15010435)
26. Harrell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. Berlin, Germany, Springer Verlag, 2001
27. Britton KA, Pradhan AD, Gaziano JM, et al. Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens 2011;24:328-334
28. Fagot-Campagna A, Balkau B, Simon D, Ducimetière P, Eschwège E. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997;26:542-550 (Pubitemid 27267775)
29. He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK. Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 1999;159:498-503 (Pubitemid 29108916)
30. Liese AD, Mayer-Davis EJ, Chambless LE, et al.; Atherosclerosis Risk in Communities Study Investigators. Elevated fasting insulin predicts incident hypertension: the ARIC study. J Hypertens 1999;17:1169-1177 (Pubitemid 29389565)
31. Vaccaro O, Imperatore G, Iovino V, Iovine C, Rivellese AA, Riccardi G. Does impaired glucose tolerance predict hypertension? A prospective analysis. Diabetologia 1996;39:70-76 (Pubitemid 26029734)
32. Savoia C, Schiffrin EL. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond) 2007;112:375-384 (Pubitemid 46587452)
33. Cosentino F, Lüscher TF. Effects of blood pressure and glucose on endothelial function. Curr Hypertens Rep 2001;3:79-88
34. Marshall SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes. BMJ 2006;333:475-480 (Pubitemid 44343444)
35. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-790 (Pubitemid 30212409)
36. Goh SY, Cooper ME. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008;93:1143-1152 (Pubitemid 351519698)
37. Monnier VM, Sell DR, Genuth S. Glycation products as markers and predictors of the progression of diabetic complications. Ann N Y Acad Sci 2005;1043:567-581 (Pubitemid 41123947)
38. Levey A, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11:155A